These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 22394497)
21. Methylation and mutation of the inhibin‑α gene in human melanoma cells and regulation of PTEN expression and AKT/PI3K signaling by a demethylating agent. Ko H; Ahn HJ; Kim YI Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34958114 [TBL] [Abstract][Full Text] [Related]
22. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects. Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457 [TBL] [Abstract][Full Text] [Related]
23. Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer. Mehrian-Shai R; Chen CD; Shi T; Horvath S; Nelson SF; Reichardt JK; Sawyers CL Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5563-8. PubMed ID: 17372210 [TBL] [Abstract][Full Text] [Related]
24. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways. Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101 [TBL] [Abstract][Full Text] [Related]
25. MiR-130b can suppress proliferation of glioma cells through targeting PTEN to regulate AKT pathway. Niu H; Liu Y; Wang Y; Tian Y; Jiang H; Cao S; Yang M; Li S J BUON; 2020; 25(4):2059-2065. PubMed ID: 33099953 [TBL] [Abstract][Full Text] [Related]
26. The effect of miR-579 on the PI3K/AKT pathway in human glioblastoma PTEN mutant cell lines. Kalhori MR; Irani S; Soleimani M; Arefian E; Kouhkan F J Cell Biochem; 2019 Oct; 120(10):16760-16774. PubMed ID: 31243804 [TBL] [Abstract][Full Text] [Related]
27. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression? Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma. Bao L; Li X Mol Cell Biochem; 2019 Oct; 460(1-2):67-79. PubMed ID: 31218569 [TBL] [Abstract][Full Text] [Related]
30. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163 [TBL] [Abstract][Full Text] [Related]
31. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells. Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633 [TBL] [Abstract][Full Text] [Related]
32. Influences of LncRNA SNHG20 on proliferation and apoptosis of glioma cells through regulating the PTEN/PI3K/AKT signaling pathway. Guo LP; Zhang ZJ; Li RT; Li HY; Cui YQ Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):253-261. PubMed ID: 30657567 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
34. CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma. Tu M; Cai L; Zheng W; Su Z; Chen Y; Qi S Mol Med Rep; 2017 Apr; 15(4):1713-1721. PubMed ID: 28259931 [TBL] [Abstract][Full Text] [Related]
35. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway. Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226 [TBL] [Abstract][Full Text] [Related]
36. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879 [TBL] [Abstract][Full Text] [Related]
37. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival. Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266 [TBL] [Abstract][Full Text] [Related]
38. microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation. Liu YY; Chen MB; Cheng L; Zhang ZQ; Yu ZQ; Jiang Q; Chen G; Cao C Oncogene; 2018 May; 37(21):2890-2902. PubMed ID: 29520106 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Ramírez-Moya J; Wert-Lamas L; Santisteban P Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884 [TBL] [Abstract][Full Text] [Related]
40. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway. Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]